Three Diverse Drug Developers Award $5 Million in Later Phase Programs to eResearchTechnology
April 04 2005 - 9:05AM
PR Newswire (US)
Three Diverse Drug Developers Award $5 Million in Later Phase
Programs to eResearchTechnology Agreements Highlight eRT's
Competitive Strength to Provide the Most Comprehensive Analysis
Methods and Provide Multinational Logistics Support and Address
Massive Amounts of Data Across Four Continents PHILADELPHIA, April
4 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT),
(NASDAQ:ERES), a leading provider of centralized
electrocardiographic (ECG) collection and interpretation services,
announced today that it has been awarded more than $5 million in
cardiac safety monitoring and services for three significant later
phase development programs by three diverse sponsors. The sponsors
include a top 20 global pharma launching an important Phase III
program utilizing semi-automated readings, a significant Phase III
program extension that leverages fully manual measurement
methodology by a fast growing mid-tier organization, and eRT's
initial award from an emerging European biopharmaceutical for
semi-automated readings for a critical Phase III program. The three
programs include research sites distributed across four continents.
eRT is providing comprehensive support, including provision of more
than 400 units of digital 12-lead ECG equipment designed to
facilitate collection of cardiac safety data that is subsequently
provided to eRT for analysis. eRT will perform digital collection,
measurement, interpretation, review, and distribution of cardiac
safety data through its EXPeRT workflow enabled data handling
technology, the first solution in production that was designed
explicitly to meet emerging international regulatory guidance and
technical standards. "We are delighted to have been selected by
these three diverse drug developers for these important programs,
which highlight eRT's unique competitive strength to address large
programs that require substantial capabilities in the ECG
collection equipment marshalling and logistics areas, along with
substantial multilingual site support services for the duration of
these extensive, complex initiatives," said Scott Grisanti, senior
vice president of business development and chief marketing officer
at eRT. "These awards are significant because they illustrate eRT's
continued collaboration with two important long-time clients and
the addition of a new client, who has made eRT its partner of
choice for critical cardiac safety services." Based in
Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/)
is a provider of technology and services to the pharmaceutical,
biotechnology and medical device industries on a global basis. The
company is a market leader in providing centralized core-diagnostic
electrocardiographic (ECG) technology and services to evaluate
cardiac safety in clinical development. The company is also a
leader in providing technology and services to streamline the
clinical trials process by enabling its customers to automate the
collection, analysis, and distribution of clinical data in all
phases of clinical development. Statements included in this release
may constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements
involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the
company's ability to obtain new contracts and accurately estimate
net revenues due to variability in size, scope and duration of
projects, and internal issues in the sponsoring client. The
sponsors may cancel these agreements at their sole discretion. As a
result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors
that could affect the company's financial results can be found in
the company's Reports on Form 10-K filed with the Securities and
Exchange Commission. DATASOURCE: eResearchTechnology, Inc. CONTACT:
Joan Sterlacci of eResearchTechnology, Inc., +1-908-203-6473, or
Matt Hayden of Hayden Communications, +1-858-704-5065, for
eResearchTechnology Web site: http://www.ert.com/
Copyright
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jun 2024 to Jul 2024
East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about East Resources Acquisition Company (NASDAQ): 0 recent articles
More Eresearch Tech (MM) News Articles